RxMD is a therapeutics company committed to developing and establishing clinical proof of concept for early stage drug candidates.

Our collaborative business approach allows partners to access RxMD's clinical development capabilities and expertise. RxMD eschews traditional 'fee for service' relationships, operating instead under success-based outcome agreements. RxMD primarily seeks emerging market rights in our collaborations.

RxMD has partnered to successfully develop multiple commercialized products for leading global biopharmaceutical companies.

RxMD leads therapeutic candidates across the development 'valley':

Evaluation of potential scientific, regulatory and commercial risks
Preemption and minimization of these risks, thereby driving down clinical development costs
Precise clinical leadership to enhance the value of the therapeutic candidate
Improved clinical development success rates and accelerated timelines

Contact us for more information